MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HANLEY, M. R.
Right arrow Articles by MICHELL, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HANLEY, M. R.
Right arrow Articles by MICHELL, R. H.

Molecular Pharmacology, Vol 18, 78-83, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

Similar Effects of Substance P and Related Peptides on Salivation and on Phosphatidylinositol Turnover in Rat Salivary Glands

MICHAEL R. HANLEY 1, C. M. LEE 1, LYNNE M. JONES 2, and ROBERT H. MICHELL 2

1 MRC Neurochemical Pharmacology Unit, Department of Pharmacology, Hills Road, Cambridge CB2 2QD, U.K.
2 Department of Biochemistry, University of Birmingham, P.O. Box 363, Birmingham B15 2TT., U.K.

The effects of substance P and related peptides on salivation in vivo and on the incorporation of 3H-inositol into rat salivary gland lipids in vitro were compared. Physalaemin was the most active peptide tested on both responses. Substance P was less potent, but was three- to sixfold more potent than peptides consisting of the C-terminal 6-10 residues of substance P. Both the C-terminal pentapeptide and the C-terminal deamidated substance P showed a dramatic reduction of potency in both assays. Substance P receptors exist in all three rat salivary glands, and a stimulation of 3H-inositol incorporation was also observed in all three glands. The close correlation between the relative activities of the different substance P-related peptides in evoking salivation and 3H-inositol incorporation strongly indicates that the same population of substance P receptors is involved in each of these two responses and is consistent with the idea that phosphatidylinositol breakdown may be a reaction involved in stimulus-response coupling at the substance P receptors of salivary glands. The incorporation of 3H-inositol into parotid gland lipids could profitably be adopted as a simple and sensitive biochemical procedure for screening the biological activity of potential agonists and antagonists at substance P receptors.

Submitted on November 7, 1979
Accepted on January 24, 1980




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
C. Severini, G. Improta, G. Falconieri-Erspamer, S. Salvadori, and V. Erspamer
The Tachykinin Peptide Family
Pharmacol. Rev., June 1, 2002; 54(2): 285 - 322.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. Trout, M. R. Corboz, and S. T. Ballard
Mechanism of substance P-induced liquid secretion across bronchial epithelium
Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L639 - L645.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
D. N. Lieberman and I. Mody
Substance P Enhances NMDA Channel Function in Hippocampal Dentate Gyrus Granule Cells
J Neurophysiol, July 1, 1998; 80(1): 113 - 119.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A. Hershey and J. Krause
Molecular characterization of a functional cDNA encoding the rat substance P receptor
Science, February 23, 1990; 247(4945): 958 - 962.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics